JPRN-UMIN000007878已完成2 期
Phase II study of auto-gamma/delta T cell therapy for multiple myeloma. - Phase II study of auto-gamma/delta T cell therapy for multiple myeloma.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have: - Uncontrolled infections; - Continuous systemic administration of steroids; - Active autoimmune diseases; - Pregnant, to be pregnant, or nursing mothers; - Active enteritis and/or gastrointestinal bleeding; - Other cancers;
研究者
相似试验
Unknown
早期 1 期
γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)Non-Hodgkin's LymphomaRelapsed or Refractory B Cell Non-Hodgkin's LymphomaChronic Lymphoblastic LeukemiaPeripheral T Cell LymphomaNCT04028440Institute of Hematology & Blood Diseases Hospital, China6
招募中
1 期
Allogeneic γδ T Cell Therapy for the Treatment of Solid TumorsMalignant Solid TumoursNCT04765462Chinese PLA General Hospital60
已完成
不适用
Intraperitoneal autologous gamma/delta T cell therapy for refractory gastric cancer with ascites.JPRN-UMIN000004130The University of Tokyo Hospital15
招募中
1 期
Safety Study for a Gamma Delta T Cell Product Used with Low Dose Radiotherapy in Patients with Locally Advanced or Metastatic NSCLC or Solid Tumors with Bone MetastasesNCT06069570Kiromic BioPharma Inc.48
Unknown
2 期
Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) PatientsNon-Hodgkin's LymphomaNCT00081783Xcyte Therapies40